Back to products

Zepdon 400 mg Tablet

Brand Name: Zepdon

Molecule: Raltegravir

Strength: 400 mg

Quantity: 60 Tablets

Form: Tablet

Packaging Type: Bottle

Manufacturer/Marketed By: Cipla

Country of Origin: India

No similar products found.

Overview

- Introduction
- Benefits
- Indications and Usage
- How it Works
- Dosage & Administration
- Side Effects
- Warning and Precaution
- Patient Guidance
- Clinical Trial & Approvals
- References

Description

Zepdon 400 mg Tablet contains raltegravir, an antiretroviral medicine used in the treatment of human immunodeficiency virus type 1 (HIV-1) infection. It belongs to a class of medicines known as integrase strand transfer inhibitors (INSTIs), which help reduce the amount of virus in the body when taken as prescribed by a qualified healthcare professional. Raltegravir works by blocking the HIV integrase enzyme, which the virus needs to insert its genetic material into human immune cells. By inhibiting this step, the medicine helps prevent the virus from multiplying and infecting new cells. Zepdon is typically used as part of combination antiretroviral therapy (ART) alongside other HIV medicines. Regular treatment with antiretroviral therapy can help control HIV infection, improve immune system function, and reduce the risk of HIV-related complications. However, it does not cure HIV, and ong

Benefits

Helps reduce HIV viral load in the body
Supports improvement of immune system function (CD4 cells)
Part of modern antiretroviral therapy (ART) regimens
Integrase inhibitor mechanism targeting viral replication
Oral tablet formulation for convenient daily treatment

Indications and Usage

Zepdon (raltegravir) may be prescribed for:

Human Immunodeficiency Virus type 1 (HIV-1) infection
Use in combination with other antiretroviral medicines
Treatment of adult and pediatric patients as part of HIV management

Treatment decisions are based on viral load, immune status, and clinical evaluation.

How it Works

Raltegravir works by blocking the HIV integrase enzyme, which is essential for viral replication. Normally, HIV inserts its genetic material into human immune cells using this enzyme. Once integrated, the virus can replicate and spread throughout the body.

By inhibiting integrase, raltegravir prevents the virus from integrating into the host cell DNA. This blocks an important step in the HIV life cycle and reduces the ability of the virus to multiply. When used in combination with other antiretroviral medicines, this mechanism helps lower viral load and slow disease progression when taken as prescribed and monitored by a healthcare professional.

Dosage & Administration

Zepdon tablets are taken orally with water.
The medicine may be taken with or without food.
It is usually prescribed twice daily unless directed otherwise by a healthcare professional.
Tablets should be swallowed whole.
Treatment should not be stopped without medical advice, as this may lead to viral resistance.

Side Effects

Common side effects

Headache
Nausea
Diarrhea
Fatigue
Dizziness

Serious side effects

Severe allergic reactions
Liver problems
Muscle problems including rhabdomyolysis (rare)
Immune reconstitution syndrome in some patients

Patients should contact a healthcare provider if severe symptoms occur.

Warning and Precaution

Possible liver problems, especially in patients with hepatitis B or C
Risk of muscle-related side effects in rare cases
Monitor liver function and viral load during treatment
Inform healthcare providers about all medications and supplements being used
Use caution in patients with pre-existing liver disease

Patient Guidance

Take the medicine exactly as prescribed by your healthcare provider
Do not miss doses to avoid drug resistance
Attend regular HIV viral load and CD4 monitoring tests
Inform your doctor about all medications or supplements
Continue safe practices to prevent HIV transmission

Clinical Trial & Approvals

Raltegravir was the first integrase inhibitor approved for HIV treatment and has been evaluated in multiple clinical trials demonstrating significant reduction in viral load when used as part of combination antiretroviral therapy. Based on these studies, raltegravir received approval from regulatory agencies including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of HIV-1 infection.

References

FDA – Raltegravir Prescribing Information
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022145s043lbl.pdf
World Health Organization – HIV Treatment Guidelines
https://www.who.int
Drugs.com – Raltegravir Drug Information
https://www.drugs.com/raltegravir.html
ClinicalTrials.gov – Raltegravir Clinical Studies
https://clinicaltrials.gov
National Institutes of Health – HIV Treatment Information
https://hivinfo.nih.gov

Prescription & documentation note

Zepdon 400 mg Tablet is typically supplied against a valid prescription. For international orders, patients may need to provide documents such as a licensed physician’s prescription and identification, depending on the destination country’s import regulations.

Reviews

Clear filters

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.